Question explored with the scientific record
SV40
SV40 is a monkey virus that contaminated polio vaccines from 1955 to 1963, and the evidence for it causing human cancers is real but inconsistent.
The story starts with a known contamination. Polio vaccines given to millions of people between 1955 and 1963 were grown in monkey kidney cells and carried live SV40 virus [6]. The question is whether that exposure later caused cancer.
The evidence for an association is strongest in certain tumor types. A 2014 study found SV40 antibodies in 44% of osteosarcoma patients versus 17% of healthy controls [1]. SV40 DNA has been detected in a substantial fraction of non-Hodgkin lymphoma cases, in both HIV-infected and uninfected patients, while zero of 186 non-malignant lymphoid samples tested positive [5]. In brain tumors, detection rates range from 11% to 59% across studies, averaging about 36% [8]. SV40-positive mesothelioma cells produce about five times more vascular endothelial growth factor than SV40-negative cells, a mechanism that could drive tumor growth [2].
But the picture is not clean. Several epidemiology studies comparing people who received the contaminated vaccines to those who did not have failed to find a clear elevation in cancer risk [6]. The relative risks across nine different studies range from 0.30 to 4.00, with most clustering near 1.0 and wide confidence intervals [6]. A 2004 case-control study found no significant link between SV40 antibodies and non-Hodgkin lymphoma [7]. The virus's causal role in human tumors remains unproven [3].
The mechanism is biologically plausible. SV40's large T-antigen can immortalize cells by disabling tumor suppressor proteins like p53 and Rb [9][10]. The virus can also suppress nitric oxide production in mesothelial cells, potentially helping transformed cells survive [4].
The strongest evidence for human harm comes from the tumor-detection studies, not the epidemiology. The epidemiology is inconclusive, partly because not everyone who got a polio shot received a contaminated batch, and the dose of live virus varied [3]. The detection studies show SV40 is present in some human tumors at rates above background, but they cannot prove the virus caused the cancer.
My call: SV40 is a plausible human tumor virus with documented presence in several cancer types, but the epidemiological evidence for a causal link from contaminated vaccines is inconclusive. Confidence: moderate.
Sources used 10
-
Significant association between human osteosarcoma and simian virus 40
This study investigates the association between human osteosarcoma and Simian Virus 40 (SV40) by analyzing serum samples for SV40-specific antibodies, revealing a significantly higher prevalence in osteosarcoma patients compared to healthy controls.
DOI: 10.1002/cncr.29137 -
The Presence of Simian-Virus 40 Sequences in Mesothelioma and Mesothelial Cells Is Associated with High Levels of Vascular Endothelial Growth Factor
This study investigates the association between simian virus 40 (SV40) presence and increased vascular endothelial growth factor (VEGF) release in human malignant mesothelioma (MM) cells, revealing that SV40-positive MM cells and SV40-transfected normal human mesothelial cells (…
DOI: 10.1165/ajrcmb.26.2.4673 -
Increasing Evidence for Involvement of SV40 in Human Cancer
This commentary argues that accumulating molecular detection studies support considering SV40 a candidate human tumor virus, while the virus's causal role in tumor development remains unproven.
DOI: 10.1155/2001/857621 -
Simian Virus 40 Infection Down-Regulates the Expression of Nitric Oxide Synthase in Human Mesothelial Cells
This study investigates the role of SV40 in modulating nitric oxide synthase activity and expression in human mesothelial and malignant mesothelioma cells exposed to crocidolite asbestos, revealing that SV40 inhibits nitric oxide production and nuclear factor kappa B activation,…
DOI: 10.1158/0008-5472.CAN-04-0486 -
Association between simian virus 40 and non-Hodgkin lymphoma
This study investigates the association between simian virus 40 (SV40) and non-Hodgkin lymphoma in HIV-1-infected and uninfected patients, finding that SV40 DNA sequences are significantly present in a substantial proportion of non-Hodgkin lymphoma cases.
DOI: 10.1016/S0140-6736(02)07950-3 -
Polio vaccines, Simian Virus 40, and human cancer: the epidemiologic evidence for a causal association
This study reviews the epidemiological evidence regarding the potential causal association between Simian Virus 40 (SV40) contamination in polio vaccines and human cancer, concluding that the evidence is inconclusive and highlighting the need for improved methodologies in future…
DOI: 10.1038/sj.onc.1207877 -
Case-Control Study of Simian Virus 40 and Non-Hodgkin Lymphoma in the United States
This case-control study investigates the association between seropositivity for simian virus 40 (SV40) and the risk of non-Hodgkin lymphoma (NHL) in the United States, finding no significant link between SV40 exposure and NHL incidence.
DOI: 10.1093/jnci/djh266 -
Is SV40 a tumorigenic human pathogen?
This study investigates whether SV40, a simian virus, has crossed the species barrier to become a tumorigenic pathogen in humans, finding SV40 DNA in a significant percentage of brain tumors, which suggests a potential link to human oncogenesis.
DOI: 10.1111/j.1750-3639.1999.tb00208.x -
Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3′ end of sv40 gene A
This study investigates the requirements for the immortalization of primary mouse embryo fibroblasts using SV40 large T antigen mutants, revealing that specific amino acids and regions of the protein are critical for this process.
DOI: 10.1016/0042-6822(88)90396-0 -
Simian Virus 40 T-Antigen-Mediated Gene Regulation in Enterocytes Is Controlled Primarily by the Rb-E2F Pathway
This study uses transgenic mouse enterocytes expressing SV40 large T antigen (TAg) and its mutants to show that TAg-driven gene regulation is largely controlled by the Rb-E2F pathway via an intact LXCXE motif and J domain, with TAg N136 mirroring TAg wt in activating E2F targets…
DOI: 10.1128/jvi.00583-09